A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

NCT04728984 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Uremic Pruritus

Interventions

DRUG: Nalfurafine Hydrochloride
DRUG: Nalfurafine Hydrochloride+Placebo
DRUG: Placebo

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.